Logo image of SXP.CA

SUPREMEX INC (SXP.CA) Stock Fundamental Analysis

Canada - TSX:SXP - CA86863R1055 - Common Stock

3.72 CAD
-0.03 (-0.8%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

5

SXP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 12 industry peers in the Paper & Forest Products industry. SXP has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on SXP.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SXP was profitable.
SXP had a positive operating cash flow in the past year.
Of the past 5 years SXP 4 years were profitable.
Each year in the past 5 years SXP had a positive operating cash flow.
SXP.CA Yearly Net Income VS EBIT VS OCF VS FCFSXP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

1.2 Ratios

The Return On Assets of SXP (-6.83%) is comparable to the rest of the industry.
SXP has a Return On Equity (-13.82%) which is in line with its industry peers.
The Return On Invested Capital of SXP (7.67%) is better than 91.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SXP is significantly above the industry average of 4.00%.
Industry RankSector Rank
ROA -6.83%
ROE -13.82%
ROIC 7.67%
ROA(3y)4.17%
ROA(5y)4.84%
ROE(3y)8.5%
ROE(5y)10.24%
ROIC(3y)10.37%
ROIC(5y)9.84%
SXP.CA Yearly ROA, ROE, ROICSXP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

SXP's Operating Margin of 5.83% is amongst the best of the industry. SXP outperforms 83.33% of its industry peers.
In the last couple of years the Operating Margin of SXP has remained more or less at the same level.
SXP has a Gross Margin of 27.87%. This is amongst the best in the industry. SXP outperforms 91.67% of its industry peers.
In the last couple of years the Gross Margin of SXP has grown nicely.
Industry RankSector Rank
OM 5.83%
PM (TTM) N/A
GM 27.87%
OM growth 3Y-10.52%
OM growth 5Y0.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y2.5%
SXP.CA Yearly Profit, Operating, Gross MarginsSXP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

SXP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SXP has been reduced compared to 1 year ago.
Compared to 5 years ago, SXP has less shares outstanding
The debt/assets ratio for SXP is higher compared to a year ago.
SXP.CA Yearly Shares OutstandingSXP.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SXP.CA Yearly Total Debt VS Total AssetsSXP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.95, we must say that SXP is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.95, SXP is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
The Debt to FCF ratio of SXP is 3.62, which is a good value as it means it would take SXP, 3.62 years of fcf income to pay off all of its debts.
SXP has a better Debt to FCF ratio (3.62) than 91.67% of its industry peers.
SXP has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
SXP has a Debt to Equity ratio (0.32) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.62
Altman-Z 0.95
ROIC/WACC1.23
WACC6.23%
SXP.CA Yearly LT Debt VS Equity VS FCFSXP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.3 Liquidity

SXP has a Current Ratio of 1.12. This is a normal value and indicates that SXP is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.12, SXP is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
SXP has a Quick Ratio of 1.12. This is a bad value and indicates that SXP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.68, SXP is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.68
SXP.CA Yearly Current Assets VS Current LiabilitesSXP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

The earnings per share for SXP have decreased strongly by -27.02% in the last year.
Measured over the past years, SXP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.46% on average per year.
The Revenue has decreased by -3.54% in the past year.
The Revenue has been growing slightly by 7.95% on average over the past years.
EPS 1Y (TTM)-27.02%
EPS 3Y-9.3%
EPS 5Y13.46%
EPS Q2Q%-96.25%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y7.47%
Revenue growth 5Y7.95%
Sales Q2Q%-4.87%

3.2 Future

SXP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.46% yearly.
Based on estimates for the next years, SXP will show a small growth in Revenue. The Revenue will grow by 7.68% on average per year.
EPS Next Y-37.68%
EPS Next 2Y10.67%
EPS Next 3Y40.46%
EPS Next 5YN/A
Revenue Next Year-4.05%
Revenue Next 2Y-2.7%
Revenue Next 3Y7.68%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SXP.CA Yearly Revenue VS EstimatesSXP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
SXP.CA Yearly EPS VS EstimatesSXP.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.94, which indicates a very decent valuation of SXP.
100.00% of the companies in the same industry are more expensive than SXP, based on the Price/Earnings ratio.
SXP is valuated cheaply when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
SXP is valuated cheaply with a Price/Forward Earnings ratio of 6.46.
SXP's Price/Forward Earnings ratio is rather cheap when compared to the industry. SXP is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SXP to the average of the S&P500 Index (22.57), we can say SXP is valued rather cheaply.
Industry RankSector Rank
PE 10.94
Fwd PE 6.46
SXP.CA Price Earnings VS Forward Price EarningsSXP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

SXP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SXP is cheaper than 91.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SXP is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.05
EV/EBITDA 4.83
SXP.CA Per share dataSXP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of SXP may justify a higher PE ratio.
A more expensive valuation may be justified as SXP's earnings are expected to grow with 40.46% in the coming years.
PEG (NY)N/A
PEG (5Y)0.81
EPS Next 2Y10.67%
EPS Next 3Y40.46%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.33%, SXP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.04, SXP pays a better dividend. On top of this SXP pays more dividend than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, SXP pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.33%

5.2 History

The dividend of SXP decreases each year by -8.37%.
SXP has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of SXP decreased in the last 3 years.
Dividend Growth(5Y)-8.37%
Div Incr Years2
Div Non Decr Years2
SXP.CA Yearly Dividends per shareSXP.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

SXP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-29.86%
EPS Next 2Y10.67%
EPS Next 3Y40.46%
SXP.CA Yearly Income VS Free CF VS DividendSXP.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

SUPREMEX INC

TSX:SXP (10/10/2025, 7:00:00 PM)

3.72

-0.03 (-0.8%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners0.76%
Inst Owner ChangeN/A
Ins Owners12.16%
Ins Owner ChangeN/A
Market Cap91.36M
Analysts80
Price Target5.1 (37.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.33%
Yearly Dividend0.17
Dividend Growth(5Y)-8.37%
DP-29.86%
Div Incr Years2
Div Non Decr Years2
Ex-Date09-10 2025-09-10 (0.5)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.24%
Min EPS beat(2)-97.88%
Max EPS beat(2)-40.59%
EPS beat(4)1
Avg EPS beat(4)-27.33%
Min EPS beat(4)-97.88%
Max EPS beat(4)100.02%
EPS beat(8)1
Avg EPS beat(8)-27.21%
EPS beat(12)3
Avg EPS beat(12)-14.95%
EPS beat(16)7
Avg EPS beat(16)9.45%
Revenue beat(2)0
Avg Revenue beat(2)-4.1%
Min Revenue beat(2)-6.84%
Max Revenue beat(2)-1.35%
Revenue beat(4)0
Avg Revenue beat(4)-3.29%
Min Revenue beat(4)-6.84%
Max Revenue beat(4)-1.35%
Revenue beat(8)1
Avg Revenue beat(8)-3.62%
Revenue beat(12)3
Avg Revenue beat(12)-1.97%
Revenue beat(16)7
Avg Revenue beat(16)1.27%
PT rev (1m)0%
PT rev (3m)2.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-38.46%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.88%
Valuation
Industry RankSector Rank
PE 10.94
Fwd PE 6.46
P/S 0.33
P/FCF 4.05
P/OCF 3.8
P/B 0.81
P/tB 2
EV/EBITDA 4.83
EPS(TTM)0.34
EY9.14%
EPS(NY)0.58
Fwd EY15.48%
FCF(TTM)0.92
FCFY24.68%
OCF(TTM)0.98
OCFY26.31%
SpS11.18
BVpS4.6
TBVpS1.86
PEG (NY)N/A
PEG (5Y)0.81
Profitability
Industry RankSector Rank
ROA -6.83%
ROE -13.82%
ROCE 10.32%
ROIC 7.67%
ROICexc 7.77%
ROICexgc 13.87%
OM 5.83%
PM (TTM) N/A
GM 27.87%
FCFM 8.21%
ROA(3y)4.17%
ROA(5y)4.84%
ROE(3y)8.5%
ROE(5y)10.24%
ROIC(3y)10.37%
ROIC(5y)9.84%
ROICexc(3y)10.45%
ROICexc(5y)10%
ROICexgc(3y)17.12%
ROICexgc(5y)17.28%
ROCE(3y)13.97%
ROCE(5y)13.25%
ROICexcg growth 3Y-16.26%
ROICexcg growth 5Y0.65%
ROICexc growth 3Y-11.34%
ROICexc growth 5Y2.58%
OM growth 3Y-10.52%
OM growth 5Y0.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y2.5%
F-Score6
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.62
Debt/EBITDA 1.02
Cap/Depr 7.69%
Cap/Sales 0.54%
Interest Coverage 3.3
Cash Conversion 67.91%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.68
Altman-Z 0.95
F-Score6
WACC6.23%
ROIC/WACC1.23
Cap/Depr(3y)21.35%
Cap/Depr(5y)22.31%
Cap/Sales(3y)1.28%
Cap/Sales(5y)1.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.02%
EPS 3Y-9.3%
EPS 5Y13.46%
EPS Q2Q%-96.25%
EPS Next Y-37.68%
EPS Next 2Y10.67%
EPS Next 3Y40.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y7.47%
Revenue growth 5Y7.95%
Sales Q2Q%-4.87%
Revenue Next Year-4.05%
Revenue Next 2Y-2.7%
Revenue Next 3Y7.68%
Revenue Next 5YN/A
EBIT growth 1Y-26.24%
EBIT growth 3Y-3.83%
EBIT growth 5Y8.69%
EBIT Next Year471.83%
EBIT Next 3Y111.94%
EBIT Next 5YN/A
FCF growth 1Y-12.88%
FCF growth 3Y5.18%
FCF growth 5Y17.3%
OCF growth 1Y-28.92%
OCF growth 3Y2.27%
OCF growth 5Y9.72%